Podcast – MARQUE Study, Managing Agitation in Dementia
MARQUE explores agitation in dementia care, testing staff training in care homes to improve wellbeing, reduce distress, and support better daily care.
MARQUE explores agitation in dementia care, testing staff training in care homes to improve wellbeing, reduce distress, and support better daily care.
This review, aims to assess the ability of CSF tau biomarkers (t-tau and p-tau) and the CSF tau (t-tau or p-tau)/ABeta ratio to enable the detection of Alzheimer’s disease pathology in patients with mild cognitive impairment (MCI).
Parkinson’s disease comes in many flavors, posing a challenge for clinical trials. Knowing how the disease progresses may improve chances of success. A longitudinal study from the LRRK2 Ashkenazi Jewish Consortium provides just such data.
https://www.alzforum.org/news/research-news/does-daytime-drowsiness-foreshadow-av-accumulation
Paul Brownbill, is from the University of South Wales, in his blog he talks about ‘Quality of Life and the Role of Communal Space in Sheltered Housing’
With Pfizer shutting down its neuroscience unit and a long list of failed late-stage trials, the sheer difficulty of improving the treatment of Alzheimer’s disease has become painfully clear. How can researchers crack the mystery of this much-feared neurodegenerative disease?
I am a researcher in the School of Medicine at Cardiff University. My background is in nursing, but I have been an applied health researcher for the past 5 years,…
Overviews of systematic reviews are a relatively new approach to synthesising evidence, and research methods and associated guidance are developing.